{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T20:36:35Z","timestamp":1768941395375,"version":"3.49.0"},"reference-count":52,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed Rep"],"DOI":"10.3892\/br.2025.2096","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T07:18:16Z","timestamp":1764746296000},"page":"1-19","source":"Crossref","is-referenced-by-count":0,"title":["Cardiorenal safety and efficacy of angiotensin receptor\u2011neprilysin inhibitors in heart failure across the ejection fraction spectrum: A meta\u2011analysis and meta\u2011regression of RCTs with 28,001 patients"],"prefix":"10.3892","volume":"24","author":[{"given":"Derren","family":"Rampengan","sequence":"first","affiliation":[{"name":"Medical Doctor Program, Faculty of Medicine, Universitas Sam Ratulangi, Manado 95115, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stevanus","family":"Surya","sequence":"additional","affiliation":[{"name":"Medical Doctor Program, Faculty of Medicine, Universitas Udayana, Denpasar 80232, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Tjandra","sequence":"additional","affiliation":[{"name":"Medical Doctor Program, Faculty of Medicine, Universitas Diponegoro, Semarang 50275, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Lele","sequence":"additional","affiliation":[{"name":"Medical Doctor Program, Faculty of Medicine, Universitas Kristen Indonesia, Jakarta 10430, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Starry","family":"Rampengan","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Vascular Medicine R.D. Kandou Central General Hospital, Faculty of Medicine, Universitas Sam Ratulangi, Manado 95115, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ika","family":"Kadariswantiningsih","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Airlangga University, Surabaya, East Java 60131, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bulat","family":"Idrisov","sequence":"additional","affiliation":[{"name":"Health Services Research Department of Health Systems and Population Health, University of Washington, Seattle, Washington 98195, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Idrisova","sequence":"additional","affiliation":[{"name":"Health Services Research Department of Health Systems and Population Health, University of Washington, Seattle, Washington 98195, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maulana","family":"Empitu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Airlangga University, Surabaya, East Java 60131, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"key20260120084917_b1-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/CIR.0000000000001063","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: A report of the American College of Cardiology\/American heart association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"key20260120084917_b2-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.carpath.2011.11.007","article-title":"The pathophysiology of heart failure","volume":"21","author":"Kemp","year":"2012","journal-title":"Cardiovasc Pathol"},{"key":"key20260120084917_b3-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: A comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"e0172745","key":"key20260120084917_b4-BR-24-2-02096","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172745","article-title":"Real world heart failure epidemiology and outcome: A population-based analysis of 88,195 patients","volume":"12","author":"Farr\u00e9","year":"2017","journal-title":"PLoS One"},{"key":"key20260120084917_b5-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1016\/j.jacc.2014.08.016","article-title":"Healthy lifestyles and personal responsibility","volume":"64","author":"Heidenreich","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"key20260120084917_b6-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"key20260120084917_b7-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.rec.2016.11.005","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"74","author":"Ponikowski","year":"2016","journal-title":"Kardiol Pol"},{"key":"key20260120084917_b8-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"key20260120084917_b9-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"issue":"e124","key":"key20260120084917_b10-BR-24-2-02096","article-title":"Efficacy of acetazolamide and loop diuretics combinatorial therapy in congestive heart failure: A meta-analysis","volume":"2","author":"Duta","year":"2024","journal-title":"Narra X"},{"key":"key20260120084917_b11-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.2174\/0113816128316596240625110337","article-title":"Diuretic combination therapy in acute heart failure: An updated review","volume":"30","author":"Villaschi","year":"2024","journal-title":"Curr Pharm Des"},{"issue":"e44624","key":"key20260120084917_b12-BR-24-2-02096","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.44624","article-title":"Combination diuretic therapy with thiazides: A systematic review on the beneficial approach to overcome refractory fluid overload in heart failure","volume":"15","author":"Gogikar","year":"2023","journal-title":"Cureus"},{"key":"key20260120084917_b13-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.amjcard.2022.10.026","article-title":"Network meta-analysis comparing angiotensin receptor-neprilysin inhibitors, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors in heart failure with reduced ejection fraction","volume":"187","author":"Park","year":"2023","journal-title":"Am J Cardiol"},{"key":"key20260120084917_b14-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"3841","DOI":"10.1002\/ehf2.12974","article-title":"Efficacy and safety of sacubitril-valsartan in heart failure: A meta-analysis of randomized controlled trials","volume":"7","author":"Zhang","year":"2020","journal-title":"ESC Hear Fail"},{"issue":"n71","key":"key20260120084917_b15-BR-24-2-02096","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"key20260120084917_b16-BR-24-2-02096"},{"issue":"80","key":"key20260120084917_b17-BR-24-2-02096","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0259-8","article-title":"Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non-Cochrane reviews","volume":"5","author":"J\u00f8rgensen","year":"2016","journal-title":"Syst Rev"},{"key":"key20260120084917_b18-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"key20260120084917_b19-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.jchf.2014.09.001","article-title":"Combined neprilysin and renin-angiotensin system inhibition for the treatment of heart failure","volume":"2","author":"Vardeny","year":"2014","journal-title":"JACC Heart Fail"},{"key":"key20260120084917_b20-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1002\/ejhf.2738","article-title":"Health-related quality of life outcomes in PARAGON-HF","volume":"24","author":"Chandra","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"key20260120084917_b21-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1001\/jama.2019.12843","article-title":"Effect of sacubitril-valsartan vs enalapril on aortic stiffness in patients with heart failure and reduced ejection fraction: A Randomized clinical trial","volume":"322","author":"Desai","year":"2019","journal-title":"JAMA"},{"key":"key20260120084917_b22-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1536\/ihj.19-231","article-title":"The impact of sacrubitril\/valsartan on clinical treatment and hs-cTnT and NT-ProBNP serum levels and the left ventricular function in patients with chronic heart failure","volume":"61","author":"Gao","year":"2020","journal-title":"Int Heart J"},{"key":"key20260120084917_b23-BR-24-2-02096","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4236\/ojim.2020.101003","article-title":"Effect of angiotensin receptor-neprilysin inhibitor versus valsartan on cardiac status in patients with chronic heart failure with reduced ejection fraction: A Randomized clinical trial in Rangpur Medical College Hospital, Bangladesh","volume":"10","author":"Ghafur","year":"2020","journal-title":"Open J Intern Med"},{"key":"key20260120084917_b24-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1002\/ejhf.2355","article-title":"A randomized clinical trial on the short-term effects of 12-week sacubitril\/valsartan vs. enalapril on peak oxygen consumption in patients with heart failure with reduced ejection fraction: Results from the ACTIVITY-HF study","volume":"23","author":"Halle","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"key20260120084917_b25-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1161\/CIRCULATIONAHA.118.037077","article-title":"Angiotensin receptor neprilysin inhibitor for functional mitral regurgitation","volume":"139","author":"Kang","year":"2019","journal-title":"Circulation"},{"key":"key20260120084917_b26-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3233\/CH-201032","article-title":"Effect of sacubitril valsartan on cardiac function and endothelial function in patients with chronic heart failure with reduced ejection fraction","volume":"77","author":"Li","year":"2021","journal-title":"Clin Hemorheol Microcirc"},{"key":"key20260120084917_b27-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1001\/jamacardio.2021.4567","article-title":"Effect of treatment with sacubitril\/valsartan in patients with advanced heart failure and reduced ejection fraction: A Randomized clinical trial","volume":"7","author":"Mann","year":"2022","journal-title":"JAMA Cardiol"},{"key":"key20260120084917_b28-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2023.04.019","article-title":"Angiotensin-neprilysin inhibition in patients with mildly reduced or preserved ejection fraction and worsening heart failure","volume":"82","author":"Mentz","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"key20260120084917_b29-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/ejhf.2076","article-title":"OUTSTEP-HF: Randomised controlled trial comparing short-term effects of sacubitril\/valsartan versus enalapril on daily physical activity in patients with chronic heart failure with reduced ejection fraction","volume":"23","author":"Piepoli","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"key20260120084917_b30-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1001\/jama.2021.18463","article-title":"Effect of sacubitril\/valsartan vs standard medical therapies on plasma NT-proBNP concentration and submaximal exercise capacity in patients with heart failure and preserved ejection fraction: The PARALLAX Randomized clinical trial","volume":"326","author":"Pieske","year":"2021","journal-title":"JAMA"},{"key":"key20260120084917_b31-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/S0140-6736(12)61227-6","article-title":"The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: A phase 2 double-blind randomised controlled trial","volume":"380","author":"Solomon","year":"2012","journal-title":"Lancet"},{"key":"key20260120084917_b32-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1253\/circj.CJ-20-0854","article-title":"Efficacy and safety of sacubitril\/valsartan in japanese patients with chronic heart failure and reduced ejection fraction-results from the PARALLEL-HF study","volume":"85","author":"Tsutsui","year":"2021","journal-title":"Circ J"},{"key":"key20260120084917_b33-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMoa1812851","article-title":"Angiotensin-neprilysin inhibition in acute decompensated heart failure","volume":"380","author":"Velazquez","year":"2019","journal-title":"N Engl J Med"},{"key":"key20260120084917_b34-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/ejhf.232","article-title":"Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction","volume":"17","author":"Voors","year":"2015","journal-title":"Eur J Heart Fail"},{"issue":"107210","key":"key20260120084917_b35-BR-24-2-02096","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107210","article-title":"Angiotensin receptor blocker-neprilysin inhibitor for heart failure with reduced ejection fraction","volume":"204","author":"Nasrallah","year":"2024","journal-title":"Pharmacol Res"},{"issue":"e001294","key":"key20260120084917_b36-BR-24-2-02096","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2020-001294","article-title":"Beneficial and harmful effects of sacubitril\/valsartan in patients with heart failure: A systematic review of randomised clinical trials with meta-analysis and trial sequential analysis","volume":"7","author":"Nielsen","year":"2020","journal-title":"Open Hear"},{"key":"key20260120084917_b37-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1159\/000541939","article-title":"Angiotensin receptor-neprilysin inhibitor for chronic kidney disease: Strategies for renal protection","volume":"49","author":"Hishida","year":"2024","journal-title":"Kidney Blood Press Res"},{"issue":"e012272","key":"key20260120084917_b38-BR-24-2-02096","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012272","article-title":"Effects of the angiotensin-receptor neprilysin inhibitor on cardiac reverse remodeling: Meta-analysis","volume":"8","author":"Wang","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"key20260120084917_b39-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jchf.2021.09.004","article-title":"A systematic review and network meta-analysis of pharmacological treatment of heart failure with reduced ejection fraction","volume":"10","author":"Tromp","year":"2022","journal-title":"JACC Heart Fail"},{"key":"key20260120084917_b40-BR-24-2-02096","author":"van Essen"},{"key":"key20260120084917_b41-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1681\/ASN.2005030270","article-title":"Kidney function and mortality among patients with left ventricular systolic dysfunction","volume":"17","author":"Khan","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"key20260120084917_b42-BR-24-2-02096","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-021-02587-5","article-title":"Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British clinical diabetologists and the renal association UK guideline update 2021","volume":"23","author":"Banerjee","year":"2022","journal-title":"BMC Nephrol"},{"key":"key20260120084917_b43-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1161\/CIRCRESAHA.110.236687","article-title":"Estrogen signaling and cardiovascular disease","volume":"109","author":"Murphy","year":"2011","journal-title":"Circ Res"},{"issue":"100553","key":"key20260120084917_b44-BR-24-2-02096","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2020.100553","article-title":"NT-proBNP for risk prediction of cardiovascular events and all-cause mortality: The getABI-study","volume":"29","author":"Rudolf","year":"2020","journal-title":"Int J Cardiol Hear Vasc"},{"key":"key20260120084917_b45-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"73","DOI":"10.36628\/ijhf.2020.0002","article-title":"Angiotensin receptor-neprilysin inhibition (ARNI) in heart failure","volume":"2","author":"Greenberg","year":"2020","journal-title":"Int J Hear Fail"},{"key":"key20260120084917_b46-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.jacc.2016.04.060","article-title":"A test in context: Neprilysin: Function, inhibition, and biomarker","volume":"68","author":"Bayes-Genis","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"key20260120084917_b47-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10741-018-9757-1","article-title":"Practical guidance on the use of sacubitril\/valsartan for heart failure","volume":"24","author":"Sauer","year":"2019","journal-title":"Heart Fail Rev"},{"key":"key20260120084917_b48-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1001\/jamacardio.2018.0398","article-title":"Effects of sacubitril\/valsartan on physical and social activity limitations in patients with heart failure: A secondary analysis of the PARADIGM-HF trial","volume":"3","author":"Chandra","year":"2018","journal-title":"JAMA Cardiol"},{"key":"key20260120084917_b49-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.clinthera.2019.04.031","article-title":"Cost-Utility analysis of sacubitril\/valsartan use compared with standard care in chronic heart failure patients with reduced ejection fraction in South Korea","volume":"41","author":"Park","year":"2019","journal-title":"Clin Ther"},{"issue":"877237","key":"key20260120084917_b50-BR-24-2-02096","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.877237","article-title":"Application of angiotensin receptor-neprilysin inhibitor in chronic kidney disease patients: Chinese expert consensus","volume":"9","author":"Gan","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"key20260120084917_b51-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2147\/IJNRD.S259931","article-title":"Practical strategy for treating chronic kidney disease (CKD)-Associated with hypertension","volume":"13","author":"Nagata","year":"2020","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"key20260120084917_b52-BR-24-2-02096","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1536\/ihj.24-065","article-title":"Predictors of hypotension after angiotensin receptor-neprilysin inhibitor administration in patients with heart failure","volume":"65","author":"Nakano","year":"2024","journal-title":"Int Heart J"}],"container-title":["Biomedical Reports"],"original-title":[],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T06:49:23Z","timestamp":1768891763000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/br.2025.2096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":52,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,12,3]]}},"URL":"https:\/\/doi.org\/10.3892\/br.2025.2096","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"value":"2049-9434","type":"print"},{"value":"2049-9442","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]}}}